These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

75 related items for PubMed ID: 1690941

  • 1. Medical aspects on surgery in Graves' disease. Clinical review.
    Karlsson FA, Winsa B, Rastad J, Johansson H.
    Acta Chir Scand; 1990 Jan; 156(1):47-51. PubMed ID: 1690941
    [No Abstract] [Full Text] [Related]

  • 2. [The pharmacological therapy of Basedow's disease].
    Lazzarin M, Segattini L, Benati F.
    Recenti Prog Med; 1993 Oct; 84(10):698-708. PubMed ID: 7694335
    [Abstract] [Full Text] [Related]

  • 3. [The surgical treatment of Graves' disease].
    de Ruijter SH, van Dalen T, Muller AF.
    Ned Tijdschr Geneeskd; 2006 Jun 17; 150(24):1321-5. PubMed ID: 16808361
    [Abstract] [Full Text] [Related]

  • 4. Surgery for Graves' disease.
    Black BM.
    Mayo Clin Proc; 1972 Dec 17; 47(12):966-8. PubMed ID: 4117992
    [No Abstract] [Full Text] [Related]

  • 5. Remission of Graves' hyperthyroidism treated with methimazole.
    Bolaños F, González-Ortiz M, Durón H, Sánchez C.
    Rev Invest Clin; 2002 Dec 17; 54(4):307-10. PubMed ID: 12415954
    [Abstract] [Full Text] [Related]

  • 6. [Basedow's disease: surgery, the choice treatment].
    Chiampo L.
    Minerva Endocrinol; 1987 Dec 17; 12(1):49-53. PubMed ID: 2438548
    [No Abstract] [Full Text] [Related]

  • 7. Antithyroid drugs--a rational treatment for Graves' disease?
    Leclère J.
    Horm Res; 1987 Dec 17; 26(1-4):125-30. PubMed ID: 2439425
    [Abstract] [Full Text] [Related]

  • 8. Propylthiouracil and carbimazole associated-antineutrophil cytoplasmic antibodies (ANCA) in patients with Graves' disease.
    Harper L, Chin L, Daykin J, Allahabadia A, Heward J, Gough SC, Savage CO, Franklyn JA.
    Clin Endocrinol (Oxf); 2004 Jun 17; 60(6):671-5. PubMed ID: 15163328
    [Abstract] [Full Text] [Related]

  • 9. Pathogenic and clinical aspects of Graves' disease.
    Feldt-Rasmussen U, Rasmussen AK, Zimmermann-Belsing T, Hartoft-Nielsen ML.
    Exp Clin Endocrinol Diabetes; 1999 Jun 17; 107 Suppl 3():S71-4. PubMed ID: 10522809
    [No Abstract] [Full Text] [Related]

  • 10. ANCA in Graves' disease--is it antithyroid medication-induced?
    Prakash EB.
    J Assoc Physicians India; 2009 Jul 17; 57():545; author reply 545. PubMed ID: 20329422
    [No Abstract] [Full Text] [Related]

  • 11. Graves' disease.
    Rotondi M, Fonte R, Chiovato L.
    N Engl J Med; 2008 Sep 25; 359(13):1407-8; author reply 1409. PubMed ID: 18822458
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. [Basedow-Graves' disease: operative treatment (author's transl)].
    Röher HD.
    Langenbecks Arch Chir; 1978 Nov 25; 347():137-44. PubMed ID: 83518
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Concentration of TSH-receptor antibodies (TBII) in the sera of patients with immunogenic hyperthyroidism (Graves' disease) receiving antithyroid medication.
    Budihna N, Pavlin K, Porenta M.
    Radiobiol Radiother (Berl); 1987 Nov 25; 28(1):101-6. PubMed ID: 2438715
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. [Recurrence rate following thyrostatic therapy of patients with hyperthyroidism and diffuse goiter (Graves' disease). Relation to the concentration of inorganic iodine in the plasma].
    Hansen PE.
    Ugeskr Laeger; 1983 Mar 28; 145(13):980-2. PubMed ID: 6190284
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.